Birgit Gaschler‐Markefski

2.6k citations
34 papers · 1.9k indexed · 1 hit paper · h-index 17
Topics
Lung Cancer Treatments and Mutations (16 papers)Lung Cancer Diagnosis and Treatment (8 papers)Neural dynamics and brain function (7 papers)

In The Last Decade

Birgit Gaschler‐Markefski

34 papers receiving 1.9k citations

Hit Papers

Docetaxel plus nintedanib versus docetaxel plus placebo i...20142026201820222014200400600

Peers

Birgit Gaschler‐Markefski
Comparison fields: 5 of 96
  • Pulmonary and Respiratory Medicine 876
  • Oncology 759
  • Cognitive Neuroscience 468
  • Molecular Biology 408
  • Cancer Research 203
Replace Sanne de Haas with:
Sanne de Haas Switzerland
Sandi A. Kwee United States
Stephen Leong United States
Tracy Stockley Canada
John M. Sorensen United States
Christoph Reuter Germany
D. Johnston United States
Natália Becker Germany
Naim U. Rashid United States
Birgit Gaschler‐Markefski relative to Sanne de Haas Switzerland Sanne de Haas's profile →
Citations per field
00.5×2.6×
Sanne de Haas · 1×
Citations per year

Countries citing papers authored by Birgit Gaschler‐Markefski

Since Specialization
Citations

This map shows the geographic impact of Birgit Gaschler‐Markefski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Birgit Gaschler‐Markefski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Birgit Gaschler‐Markefski more than expected).

Fields of papers citing papers by Birgit Gaschler‐Markefski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Birgit Gaschler‐Markefski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Birgit Gaschler‐Markefski. The network helps show where Birgit Gaschler‐Markefski may publish in the future.

Co-authorship network of co-authors of Birgit Gaschler‐Markefski

This figure shows the co-authorship network connecting the top 25 collaborators of Birgit Gaschler‐Markefski. A scholar is included among the top collaborators of Birgit Gaschler‐Markefski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Birgit Gaschler‐Markefski. Birgit Gaschler‐Markefski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 10
3 9
4 44
5 6
6 71
7 1
8
Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trialbreakdown →
694
9 49
10 7
11 93
12 51
13 40
14 65
15 157
16 63
17 9
18 101
19 16
20 30

About Birgit Gaschler‐Markefski

Birgit Gaschler‐Markefski is a scholar working on Pulmonary and Respiratory Medicine, Statistics and Probability and Cancer Research, having authored 34 papers that have together received 1.9k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Diagnosis and Treatment (8 papers) and Neural dynamics and brain function (7 papers). The work is most often cited by research in Oncology (759 citations), Pulmonary and Respiratory Medicine (876 citations) and Cognitive Neuroscience (468 citations). Birgit Gaschler‐Markefski has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include R. Kaiser, Henning Scheich, Joachim von Pawel, José Barrueco, Martin Reck, Anders Mellemgaard, Silvia Novello, Maya Gottfried, Maciej Krzakowski and Igor Bondarenko. Their work appears in journals such as Journal of Clinical Oncology, The Lancet Oncology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026